On April 13, 2000, a public policy form was held on Capitol Hill to consider a single question: Will a greater federal role in paying for prescription drugs for older Americans dampen private sector investments in pharmaceutical research, possibly delaying or denying future medical breakthroughs? This report outlines the discussion.